Milad Shirvaliloo

Dr. Milad Shirvaliloo

Finetech in Medicine Research Center, Iran University of Medical Sciences, Tehran, Tehrān, Iran
+1
orcid
Research Associate

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Epigenomics
Verified
Journal Article
Closed access
Milad ShirvalilooMilad Shirvaliloo
Milad Shirvaliloo
Histone proteins are a primary component of chromatin; therefore, any modifications to their structure are anticipated to affect the behavior of our genetic material, which is manifested in the for... Plain language summary Histones are proteins and, as with any other protein, they are made of a series of amino acid molecules, a number of which, including arginine and lysine, can be modified by ... Tweetable abstract In this perspective article, the author revisits the histone modification-oriented original findings published in Epigenomics since 2020.

1 January 2023 in Epigenomics
Verified
Journal Article
Closed access
Milad ShirvalilooMilad Shirvaliloo
Milad Shirvaliloo
A key concept in drug discovery is the identification of candidate therapeutic targets such as long noncoding RNAs (lncRNAs) because of their extensive involvement in neoplasms, and impressionabili... Plain language summary A primary goal in the treatment of cancer is preventing the formation of new blood vessels, or angiogenesis, within the tumor, because these newly formed capillaries serve to...

14 August 2021 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
JEJohann Ebadfardzadeh
Johann Ebadfardzadeh
mandana kazemimandana kazemi
mandana kazemi
AAAli Aghazadeh
Ali Aghazadeh
MRMonireh Rezaei
Monireh Rezaei
Milad ShirvalilooMilad Shirvaliloo
Milad Shirvaliloo
RSRoghayeh Sheervalilou
Roghayeh Sheervalilou

13 January 2022 in Epigenomics
Verified
Journal Article
Open access
Milad ShirvalilooMilad Shirvaliloo
Milad Shirvaliloo
Smoking could predispose individuals to a more severe COVID-19 by upregulating a particular gene known as mdig, which is mediated through a number of well-known histone modifications. Smoking might... Lay abstract The role of smoking in development of several respiratory diseases has been clearly established. A significant proportion of these deleterious effects is mediated through epigenetic me...

1 March 2019
Verified
Journal Article
Open access
PDF file
RSRoghayeh Sheervalilou
Roghayeh Sheervalilou
HLHajie Lotfi
Hajie Lotfi
Milad ShirvalilooMilad Shirvaliloo
Milad Shirvaliloo
ASAkbar Sharifi
Akbar Sharifi
MNMasoud Nazemiyeh
Masoud Nazemiyeh
NZNosratollah Zarghami
Nosratollah Zarghami
Circulating microRNAs have been recognized as promising biomarkers for the detection of lung cancer. The objective of this study was to evaluate miR-10b, miR-1 and, miR-30a in the plasma samples of lung cancer patients to confirm any possible relevance in the early detection of lung cancer. Plasma samples from 47 ...

1 January 2021 in JCO Clinical Cancer Informatics
Verified
Journal Article
Closed access
SHSeyedeh Faezeh Hassani
Seyedeh Faezeh Hassani
MSMasoud Sayaf
Masoud Sayaf
SDSeyedeh Sara Danandeh
Seyedeh Sara Danandeh
ZNZahra Nourollahzadeh
Zahra Nourollahzadeh
MSMahshid Shahmohammadi
Mahshid Shahmohammadi
ZSZinat Shams
Zinat Shams
PURPOSE This study aims to identify potential biomarkers of hepatocellular carcinoma (HCC) occurrence/recurrence and obesity, along with the molecular mechanisms that involve these biomarkers. METHODS Three microarray data sets, namely GSE18897, GSE25097, and GSE36376 (genetic suppressor elements associated with obesity, tumor, and recurrence, respectively), were downloaded from Gene Expression Omnibus database to be investigated for their expression as differentially expressed genes (DEGs) in HCC and obesity. The functional and pathway enrichment analysis of these DEGs were identified by the Database for Annotation Visualization and Integrated Discovery. The protein-protein interaction network analysis was performed with STRING online tool and Cytoscape software. RESULTS One hundred sixty common DEGs were screened. We found that these genes were associated with certain pathways such as metabolic pathways, terpenoid backbone biosynthesis, and adipocytokine signaling pathway. The involvements of 10 genes, including RPS16, RPS7, CCT3, HNRNPA2B1, EIF4G1, PSMC4, NHP2, EGR1, FDPS, and MCM4, were identified in the subnetwork. HNRNPA2B1 and RPS7 in the GSE18897 data set, RPS16, RPS7, CCT3, HNRNPA2B1, PSMC4, NHP2, FDPS, and MCM4 in the GSE25097 data set, and RPS16, RPS7, CCT3, HNRNPA2B1, EIF4G1, PSMC4, NHP2, FDPS, and MCM4 in the GSE36376 data set exhibited positive fold changes. CONCLUSION These DEGs and pathways could be of diagnostic value as potential biomarkers involved in the pathogenesis of HCC, pertaining to both obesity and HCC occurrence/recurrence. (C) 2021 by American Society of Clinical Oncology